BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:S39-S45. [PMID: 14762838 DOI: 10.1002/lt.20040] [Cited by in Crossref: 146] [Cited by in F6Publishing: 148] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Bae JS, Lee DH, Yoo J, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB. Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection. Eur Radiol 2021;31:2461-71. [PMID: 33026503 DOI: 10.1007/s00330-020-07313-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Poon RT. Radiofrequency ablation combined with resection enhances chance for curative treatment of hepatocellular carcinoma. Ann Surg Oncol 2007;14:3299-300. [PMID: 17899286 DOI: 10.1245/s10434-007-9567-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Qi J, Wang J, Katayama H, Sen S, Liu SM. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. neo 2012;60:135-42. [DOI: 10.4149/neo_2013_018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
4 Ng KT, Lee TK, Cheng Q, Wo JY, Sun CK, Guo DY, Lim ZX, Lo CM, Poon RT, Fan ST, Man K. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int J Cancer 2010;127:859-72. [PMID: 20013809 DOI: 10.1002/ijc.25105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 25] [Article Influence: 0.4] [Reference Citation Analysis]
5 Duan X, Dong N, Zhang T, Li Q. Comparison of surgical outcomes in patients with colorectal liver metastases versus non-colorectal liver metastases: A Chinese experience: Hepatic resection for liver metastases. Hepatology Research 2012;42:296-303. [DOI: 10.1111/j.1872-034x.2011.00917.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Tabrizian P, Schwartz ME. Surgical Management of Hepatocellular Carcinoma. Mt Sinai J Med 2012;79:223-31. [DOI: 10.1002/msj.21307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. Int J Cancer. 2016;138:714-720. [PMID: 26264553 DOI: 10.1002/ijc.29802] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
8 Du Z, Li B, Wei Y, Yin J, Feng X, Chen X. A new scoring system for assessment of liver function after successful hepatectomy in patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2011;10:265-9. [DOI: 10.1016/s1499-3872(11)60044-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
9 Akateh C, Beal EW, Kim JL, Reader BF, Maynard K, Zweier JL, Whitson BA, Black SM. Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model. J Surg Res 2019;238:152-63. [PMID: 30771685 DOI: 10.1016/j.jss.2019.01.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Fuster J. Surgical treatment of hepatocellular carcinoma: should resection be performed according to Barcelona Clinic Liver Cancer classification? Hepat Oncol 2015;2:245-53. [PMID: 30191006 DOI: 10.2217/hep.15.18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, Chen PJ, Kao JH, Sheu JC, Lee CZ. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 2005;242:36-42. [PMID: 15973099 DOI: 10.1016/s0021-7697(05)80947-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Inokawa Y, Inaoka K, Sonohara F, Hayashi M, Kanda M, Nomoto S. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncol Lett 2016;12:3662-8. [PMID: 27900050 DOI: 10.3892/ol.2016.5141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
13 Nanashima A, Abo T, Kudo T, Sakamoto I, Hayashi H, Murakami G, Takeshita H, Hidaka S, Kido Y, Nagayasu T. Usefulness of examining hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hepatocellular carcinoma. Nucl Med Commun. 2013;34:478-488. [PMID: 23458853 DOI: 10.1097/mnm.0b013e32835f945f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Lin CY, Lin CC, Wang CC, Chen CL, Hu TH, Hung CH, Huang PY, Tsai MC. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. World J Surg. 2020;44:247-257. [PMID: 31559485 DOI: 10.1007/s00268-019-05197-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cheung TT, Yuen WK, Poon RT, Chan SC, Fan ST, Lo CM. Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate. Hepatobiliary Pancreat Dis Int. 2014;13:219-222. [PMID: 24686552 DOI: 10.1016/s1499-3872(14)60035-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Dai WC, Chok KS, Cheung TT, Chan AC, Chan SC, Lo CM. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017;16:382-386. [PMID: 28823368 DOI: 10.1016/s1499-3872(17)60039-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C, Mao M, Dai H, Wang XL, Xu MZ. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology. 2009;50:1453-1463. [PMID: 19676131 DOI: 10.1002/hep.23143] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
18 Li B, Zhao S, Geng R, Huo Z, Zhang H. The Sineoculis Homeobox Homolog 1 (SIX1) Gene Regulates Paclitaxel Resistance by Affecting Reactive Oxygen Species and Autophagy in Human Hepatocellular Carcinoma Cell Line HepG2. Med Sci Monit 2018;24:2271-9. [PMID: 29656300 DOI: 10.12659/msm.906361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Jiang L, Li X, Cheng Q, Zhang B. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. Tumor Biol 2015;36:7167-74. [DOI: 10.1007/s13277-015-3446-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
20 Ho YJ, Lin YM, Huang YC, Yeh KT, Lin LI, Lu JW. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker. Acta Histochem 2016;118:38-45. [PMID: 26610895 DOI: 10.1016/j.acthis.2015.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
21 Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 2009;13:2268-75. [PMID: 19662460 DOI: 10.1007/s11605-009-0977-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
22 Lee NP, Cheung ST, Poon RT, Fan ST, Luk JM. Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma. Biomark Med 2007;1:273-84. [PMID: 20477402 DOI: 10.2217/17520363.1.2.273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
23 Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol 2015; 7(2): 245-252 [PMID: 25729479 DOI: 10.4254/wjh.v7.i2.245] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
24 Shen ZY, Xia GL, Hu B, Xie YG, Wu MF. Preoperative ultrasound features as prognostic factors for patients with hepatocellular carcinoma. Radiol Med 2015;120:504-10. [PMID: 25572544 DOI: 10.1007/s11547-014-0491-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Yao F, Guo JM, Xu CF, Lou YL, Xiao BX, Zhou WH, Chen J, Hu YR, Liu Z, Hong GF. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Clin Chim Acta. 2005;361:119-127. [PMID: 15993394 DOI: 10.1016/j.cccn.2005.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
26 Lang BH, Poon RT, Fan ST, Wong J. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am J Gastroenterol. 2004;99:2158-2165. [PMID: 15554997 DOI: 10.1111/j.1572-0241.2004.40336.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
27 Nguyen MH, Keeffe EB. General management. Best Practice & Research Clinical Gastroenterology 2005;19:161-74. [DOI: 10.1016/j.bpg.2004.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
28 Chu KK, Chan SC, Fan ST, Chok KS, Cheung TT, Sharr WW, Chan AC, Lo CM. Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy. Hepatobiliary & Pancreatic Diseases International 2012;11:612-7. [DOI: 10.1016/s1499-3872(12)60232-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Gu JH, Zhu L, Jiang TA. Quantitative Ultrasound Elastography Methods in Focal Liver Lesions Including Hepatocellular Carcinoma: From Diagnosis to Prognosis. Ultrasound Q 2021;37:90-6. [PMID: 34057911 DOI: 10.1097/RUQ.0000000000000491] [Reference Citation Analysis]
30 Horvatits T, Kneidinger N, Drolz A, Roedl K, Rutter K, Kluge S, Trauner M, Fuhrmann V. Prognostic impact of ICG-PDR in patients with hypoxic hepatitis. Ann Intensive Care 2015;5:47. [PMID: 26637474 DOI: 10.1186/s13613-015-0092-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
31 Liu AM, Wang W, Luk JM. miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma. Hepat Oncol 2014;1:323-9. [PMID: 30190966 DOI: 10.2217/hep.14.9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Hsu C, Shen Y, Cheng C, Hu F, Cheng A. Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design. Contemporary Clinical Trials 2010;31:55-61. [DOI: 10.1016/j.cct.2009.08.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
33 Wang K, Guo WX, Li N, Gao CF, Shi J, Tang YF, Shen F, Wu MC, Liu SR, Cheng SQ. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. PLoS One 2015;10:e0144934. [PMID: 26674525 DOI: 10.1371/journal.pone.0144934] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
34 Jiang C, Wang Z, Xu Q, Wu X, Ding Y. Inferior Right Hepatic Vein-preserving Major Right Hepatectomy for Hepatocellular Carcinoma in Patients with Significant Fibrosis or Cirrhosis. World J Surg. 2014;38:159-167. [PMID: 24081537 DOI: 10.1007/s00268-013-2240-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
35 Hayashi PH, Di Bisceglie AM. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Infect Dis Clin North Am 2006;20:1-25. [PMID: 16527646 DOI: 10.1016/j.idc.2006.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Hsu Y, Fu H, Jeng Y, Lee P, Yang S. Proline-Directed Protein Kinase F A Is a Powerful and Independent Prognostic Predictor for Progression and Patient Survival of Hepatocellular Carcinoma. JCO 2006;24:3780-8. [DOI: 10.1200/jco.2005.03.7499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
37 Letreut Y, Hardwigsen J, Ananian P, Saisse J, Gregoire E, Richa H, Campan P. Resection of Hepatocellular Carcinoma with Tumor Thrombus in the Major Vasculature. A European Case-Control Series. Journal of Gastrointestinal Surgery 2006;10:855-62. [DOI: 10.1016/j.gassur.2005.12.011] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 5.6] [Reference Citation Analysis]
38 Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 2012;47:1125-33. [DOI: 10.1007/s00535-012-0569-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
39 Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol 2015; 7(20): 2274-2291 [PMID: 26380652 DOI: 10.4254/wjh.v7.i20.2274] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
40 Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 2014; 20(15): 4160-4166 [PMID: 24764654 DOI: 10.3748/wjg.v20.i15.4160] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
41 Mizuguchi T, Kawamoto M, Meguro M, Hui TT, Hirata K. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today. 2014;44:1-10. [PMID: 23474700 DOI: 10.1007/s00595-013-0534-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
42 Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22-e32. [PMID: 19268571 DOI: 10.1016/j.suronc.2009.02.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 6.5] [Reference Citation Analysis]
43 Luk JM, Liu AM. Proteomics of hepatocellular carcinoma in Chinese patients. OMICS 2011;15:261-6. [PMID: 21348761 DOI: 10.1089/omi.2010.0099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
44 Chan A, Kow A, Hibi T, Di Benedetto F, Serrablo A. Liver resection in Cirrhotic liver: Are there any limits? Int J Surg 2020;82S:109-14. [PMID: 32652296 DOI: 10.1016/j.ijsu.2020.06.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Ng KT, Man K, Sun CK, Lee TK, Poon RT, Lo CM, Fan ST. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer 2006;95:1050-5. [PMID: 17008870 DOI: 10.1038/sj.bjc.6603399] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
46 Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708; discussion 708-10. [PMID: 15383797 DOI: 10.1097/01.sla.0000141195.66155.0c] [Cited by in Crossref: 162] [Cited by in F6Publishing: 286] [Article Influence: 9.0] [Reference Citation Analysis]
47 Fortner JG, Fong Y. Twenty-five-year follow-up for liver resection: the personal series of Dr. Joseph G. Fortner. Ann Surg. 2009;250:908-913. [PMID: 19855260 DOI: 10.1097/sla.0b013e3181b59491] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
48 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int. 2014;2014:486407. [PMID: 24800233 DOI: 10.1155/2014/486407] [Cited by in Crossref: 37] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
49 Chan FK, Cheng KC. Laparoscopic liver resection: western versus eastern experience. Chin J Cancer Res 2014;26:243-4. [PMID: 25035649 DOI: 10.3978/j.issn.1000-9604.2014.06.16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Li B, Huang P, Qiu J, Liao Y, Hong J, Yuan Y. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. Med Oncol. 2014;31:230. [PMID: 25218269 DOI: 10.1007/s12032-014-0230-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
51 Wang Q, Li X, Qian B, Hu K, Liu B. Fluorescence imaging in the surgical management of liver cancers: Current status and future perspectives. Asian J Surg 2021:S1015-9584(21)00567-4. [PMID: 34656410 DOI: 10.1016/j.asjsur.2021.08.063] [Reference Citation Analysis]
52 Dello SA, Reisinger KW, van Dam RM, Bemelmans MH, van Kuppevelt TH, van den Broek MA, Olde Damink SW, Poeze M, Buurman WA, Dejong CH. Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One. 2012;7:e30539. [PMID: 22291982 DOI: 10.1371/journal.pone.0030539] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
53 Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology. 2006;44:836-843. [PMID: 17006919 DOI: 10.1002/hep.21353] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 5.5] [Reference Citation Analysis]
54 Fang Z, Wu L, Dai H, Hu P, Wang B, Han Q, Xu Y, Lv S, Zhu Y, Gan M, Zhou W, Zhang W. The role of vesicular overexpressed in cancer pro-survival protein 1 in hepatocellular carcinoma proliferation. Cancer Biomark 2020;28:9-20. [PMID: 32083568 DOI: 10.3233/CBM-190574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Chuang Y, Ou H, Lazo MZ, Chen C, Chen M, Weng C, Cheng Y. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis. Liver Int 2018;38:868-74. [DOI: 10.1111/liv.13608] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
56 Wang Q, Lau W, Zhang B, Zhang Z, Huang Z, Luo H, Chen X. Preoperative total cholesterol predicts postoperative outcomes after partial hepatectomy in patients with chronic hepatitis B- or C-related hepatocellular carcinoma. Surgery 2014;155:263-70. [DOI: 10.1016/j.surg.2013.08.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
57 Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15:1-11. [PMID: 21061184 DOI: 10.1007/s11605-010-1366-9] [Cited by in Crossref: 107] [Cited by in F6Publishing: 74] [Article Influence: 9.7] [Reference Citation Analysis]
58 Mizuguchi T, Nagayama M, Meguro M, Shibata T, Kaji S, Nobuoka T, Kimura Y, Furuhata T, Hirata K. Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy. J Gastrointest Surg 2009;13:325-33. [DOI: 10.1007/s11605-008-0711-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
59 Nanashima A, Masuda J, Miuma S, Sumida Y, Nonaka T, Tanaka K, Hidaka S, Sawai T, Nagayasu T. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008; 14(1): 58-63 [PMID: 18176962 DOI: 10.3748/wjg.14.58] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
60 Poon RT. Current techniques of liver transection. HPB (Oxford) 2007;9:166-73. [PMID: 18333217 DOI: 10.1080/13651820701216182] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
61 Yang LY, Chang RM, Lau WY, Ou DP, Wu W, Zeng ZJ. Mesohepatectomy for centrally located large hepatocellular carcinoma: Indications, techniques, and outcomes. Surgery. 2014;156:1177-1187. [PMID: 25444316 DOI: 10.1016/j.surg.2014.05.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
62 Lim C, Dokmak S, Farges O, Aussilhou B, Sauvanet A, Belghiti J. Reoperation for post-hepatectomy hemorrhage: increased risk of mortality. Langenbecks Arch Surg 2014;399:735-40. [DOI: 10.1007/s00423-014-1189-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
63 Ahn J, Flamm SL. Hepatocellular carcinoma. Dis Mon 2004;50:556-73. [PMID: 15616490 DOI: 10.1016/j.disamonth.2004.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
64 Shen Y, Hsu C, Cheng A. Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 2010;45:794-807. [DOI: 10.1007/s00535-010-0270-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
65 Li H, Wu JS, Wang XT, Lv P, Liu G, Tian BN, Li YY, Chen DJ, Jiang B. Major hepatectomy is a safe modality for the treatment of intrahepatic cholangiocarcinoma in selected patients complicated with cirrhosis. J Gastrointest Surg 2014;18:194-9. [PMID: 24222320 DOI: 10.1007/s11605-013-2363-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
66 Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, Greig PD, Grant DR. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation. 2006;81:1633-1639. [PMID: 16794527 DOI: 10.1097/01.tp.0000226069.66819.7e] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
67 Du ZG, Wei YG, Chen KF, Li B. An accurate predictor of liver failure and death after hepatectomy: A single institution’s experience with 478 consecutive cases. World J Gastroenterol 2014; 20(1): 274-281 [PMID: 24415882 DOI: 10.3748/wjg.v20.i1.274] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
68 Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014;4:181-189. [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
69 Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, Prasad KR. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94:1395-1402. [PMID: 17607707 DOI: 10.1002/bjs.5820] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 6.0] [Reference Citation Analysis]
70 Seong M, Song S, Oh J, Park J, Lee D. Establishment of an indocyanine green test using an automatic chemistry analyzer. Clinical Chemistry and Laboratory Medicine (CCLM) 2006;44. [DOI: 10.1515/cclm.2006.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, Chen PJ, Kao JH, Sheu JC, Lee CZ. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 2005;242:36-42. [PMID: 15973099 DOI: 10.1097/01.sla.0000167925.90380.fe] [Cited by in Crossref: 152] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
72 Ou HY, Cheng YF, Chuang YH, Hsu HW, Chen CL, Lazo MZ, Weng CC, Yu CY, Tsang LL, Huang TL, Tong YS. Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma. Dig Dis Sci. 2019;. [PMID: 31732907 DOI: 10.1007/s10620-019-05951-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Huang J, Zhang X, Tang Q, Zhang F, Li Y, Feng Z, Zhu J. Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. J Clin Pathol 2011;64:343-8. [DOI: 10.1136/jcp.2010.085142] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
74 Ivanovska I, Zhang C, Liu AM, Wong KF, Lee NP, Lewis P, Philippar U, Bansal D, Buser C, Scott M, Mao M, Poon RT, Fan ST, Cleary MA, Luk JM, Dai H. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One 2011;6:e24582. [PMID: 21949730 DOI: 10.1371/journal.pone.0024582] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
75 Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7:42-49. [PMID: 18333160 DOI: 10.1080/13651820410024067] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
76 Hsueh KC, Lee TY, Kor CT, Chen TM, Chang TM, Yang SF, Hsieh CB. The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumour Biol. 2016;37:4193-4201. [PMID: 26490991 DOI: 10.1007/s13277-015-4243-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
77 Obed A, Tsui TY, Schnitzbauer AA, Obed M, Schlitt HJ, Becker H, Lorf T. Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? Langenbecks Arch Surg 2008;393:141-7. [PMID: 18043937 DOI: 10.1007/s00423-007-0250-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
78 Li JD, Xu XF, Han J, Wu H, Xing H, Li C, Yu JJ, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Lau WY, Wu MC, Shen F, Yang T. Preoperative prealbumin level as an independent predictor of long-term prognosis after liver resection for hepatocellular carcinoma: a multi-institutional study. HPB (Oxford). 2019;21:157-166. [PMID: 30082212 DOI: 10.1016/j.hpb.2018.06.1803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
79 Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007;141:330-339. [PMID: 17349844 DOI: 10.1016/j.surg.2006.06.028] [Cited by in Crossref: 258] [Cited by in F6Publishing: 253] [Article Influence: 16.1] [Reference Citation Analysis]
80 Qi X, Ng KT, Lian QZ, Liu XB, Li CX, Geng W, Ling CC, Ma YY, Yeung WH, Tu WW, Fan ST, Lo CM, Man K. Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma. Oncotarget 2014;5:11103-20. [PMID: 25333265 DOI: 10.18632/oncotarget.2549] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
81 Park UJ, Kim YH, Kang KJ, Lim TJ. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]. Korean J Hepatol. 2008;14:371-380. [PMID: 18815460 DOI: 10.3350/kjhep.2008.14.3.371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
82 Minami Y, Kudo M. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI. Liver Cancer 2015;4:106-14. [PMID: 26697413 DOI: 10.1159/000367733] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
83 Iwamoto S, Yamaguchi T, Hongo O, Iwamoto H, Sanefuji H. Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: A retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma. Cancer 2010;116:393-9. [DOI: 10.1002/cncr.24678] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
84 Terayama M, Ito K, Takemura N, Inagaki F, Mihara F, Kokudo N. Preserving inferior right hepatic vein enabled bisegmentectomy 7 and 8 without venous congestion: a case report. Surg Case Rep 2021;7:101. [PMID: 33881648 DOI: 10.1186/s40792-021-01184-w] [Reference Citation Analysis]
85 Hayashi PH, Di Bisceglie AM. The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma. Medical Clinics of North America 2005;89:345-69. [DOI: 10.1016/j.mcna.2004.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
86 D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules. 2014;19:6393-6406. [PMID: 24853455 DOI: 10.3390/molecules19056393] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
87 Emond JC, Samstein B, Renz JF. A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg. 2005;29:124-130. [PMID: 15654659 DOI: 10.1007/s00268-004-7633-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
88 Galun DA, Bulajic P, Zuvela M, Basaric D, Ille T, Milicevic MN. Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country. World J Surg. 2012;36:1657-1665. [PMID: 22395347 DOI: 10.1007/s00268-012-1544-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
89 Benzoni E, Cojutti A, Lorenzin D, Adani GL, Baccarani U, Favero A, Zompicchiati A, Bresadola F, Uzzau A. Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg. 2007;392:45-54. [PMID: 16983576 DOI: 10.1007/s00423-006-0084-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
90 Curro G, Jiao L, Scisca C, Baccarani U, Mucciardi M, Habib N, Navarra G. Radiofrequency-Assisted liver resection in cirrhotic patients with hepatocellular carcinoma. J Surg Oncol 2008;98:407-10. [DOI: 10.1002/jso.21129] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
91 van der Bilt J, Livestro D, Borren A, van Hillegersberg R, Borel Rinkes I. European Survey on the Application of Vascular Clamping in Liver Surgery. Dig Surg 2008;24:423-35. [DOI: 10.1159/000108325] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
92 Wang Y, Zhang Y, Peitgen HO, Schenk A, Yuan L, Wei G, Sun Y. Precise local resection for hepatocellular carcinoma based on tumor-surrounding vascular anatomy revealed by 3D analysis. Dig Surg. 2012;29:99-106. [PMID: 22441716 DOI: 10.1159/000336289] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
93 Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12:966-971. [PMID: 16598792 DOI: 10.1002/lt.20761] [Cited by in Crossref: 199] [Cited by in F6Publishing: 159] [Article Influence: 12.4] [Reference Citation Analysis]
94 He S, Hu XW, Wang D, Han LF, Zhang DC, Wei C. Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2016; Mar 23. [Epub ahead of print]. [PMID: 27016891 DOI: 10.1016/j.clinre.2016.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
95 Sun S, Xu MZ, Poon RT, Day PJ, Luk JM. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res. 2010;9:70-78. [PMID: 19522540 DOI: 10.1021/pr9002118] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
96 Taefi A, Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M. Surgical resection versus liver transplant for patients with hepatocellular carcinoma. Cochrane Database Syst Rev 2013;:CD006935. [PMID: 23813393 DOI: 10.1002/14651858.CD006935.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
97 Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg. 2009;13:2268-2275. [PMID: 19662460 DOI: 10.1007/s11605-009-0977-5.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Chapelle T, Op De Beeck B, Huyghe I, Francque S, Driessen A, Roeyen G, Ysebaert D, De Greef K. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? HPB (Oxford). 2016;18:494-503. [PMID: 27317953 DOI: 10.1016/j.hpb.2015.08.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
99 Delis SG, Dervenis C. Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease. World J Gastroenterol 2008; 14(22): 3452-3460 [PMID: 18567070 DOI: 10.3748/wjg.14.3452] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
100 Scoparo CT, Valdameri G, Worfel PR, Guterres FALB, Martinez GR, Winnischofer SMB, Di Pietro A, Rocha MEM. Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity. Mol Cell Biochem 2015;409:123-33. [DOI: 10.1007/s11010-015-2518-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
101 Nanashima A, Tobinaga S, Kunizaki M, Miuma S, Taura N, Takeshita H, Hidaka S, Sawai T, Nakao K, Nagayasu T. Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy. J Surg Oncol 2010;101:557-63. [PMID: 20213729 DOI: 10.1002/jso.21534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
102 Delis SG, Bakoyiannis A, Biliatis I, Athanassiou K, Tassopoulos N, Dervenis C. Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2009;11:351-357. [PMID: 19718364 DOI: 10.1111/j.1477-2574.2009.00067.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
103 Ingle PV, Samsudin SZ, Chan PQ, Ng MK, Heng LX, Yap SC, Chai AS, Wong AS. Development and novel therapeutics in hepatocellular carcinoma: a review. Ther Clin Risk Manag. 2016;12:445-455. [PMID: 27042086 DOI: 10.2147/tcrm.s92377] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
104 Wang YL, Chen CM, Wang XM, Wang L. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2016;40:51-6. [PMID: 26186881 DOI: 10.1016/j.clinre.2015.05.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
105 Qi YJ, Ward DG, Pang C, Wang QM, Wei W, Ma J, Zhang J, Lou Q, Shimwell NJ, Martin A, Wong N, Chao WX, Wang M, Ma YF, Johnson PJ. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma. Proteomics 2014;14:186-95. [PMID: 24259486 DOI: 10.1002/pmic.201300226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
106 Pesce A, Scilletta R, Branca A, Nigro L, Montineri A, Larocca L, Fatuzzo F, Castaing M, Puleo S. Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma? HPB (Oxford) 2012;14:403-8. [PMID: 22568417 DOI: 10.1111/j.1477-2574.2012.00465.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
107 Benzoni E, Lorenzin D, Favero A, Adani G, Baccarani U, Molaro R, Zompicchiatti A, Saccomano E, Avellini C, Bresadola F, Uzzau A. Liver Resection for Hepatocellular Carcinoma: a Multivariate Analysis of Factors Associated with Improved Prognosis. the Role of Clinical, Pathological and Surgical Related Factors. Tumori 2007;93:264-8. [DOI: 10.1177/030089160709300306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
108 Bremner KE, Bayoumi AM, Sherman M, Krahn MD. Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis. Can J Gastroenterol 2007;21:491-500. [PMID: 17703248 DOI: 10.1155/2007/182383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
109 Schreckenbach T, Liese J, Bechstein WO, Moench C. Posthepatectomy liver failure. Dig Surg. 2012;29:79-85. [PMID: 22441624 DOI: 10.1159/000335741] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
110 Kim RD, Reed AI, Fujita S, Foley DP, Mekeel KL, Hemming AW. Consensus and controversy in the management of hepatocellular carcinoma. J Am Coll Surg. 2007;205:108-123. [PMID: 17617340 DOI: 10.1016/j.jamcollsurg.2007.02.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
111 Xie Z, Zhou F, Yang Y, Li L, Lei Y, Lin X, Li H, Pan X, Chen J, Wang G, Liu H, Jiang J, Wu B. Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. EBioMedicine 2018;33:57-67. [PMID: 30045829 DOI: 10.1016/j.ebiom.2018.06.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
112 Whang-peng J, Cheng A, Hsu C, Chen C. Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma. Journal of Experimental & Clinical Medicine 2010;2:93-103. [DOI: 10.1016/s1878-3317(10)60016-2] [Cited by in Crossref: 18] [Article Influence: 1.5] [Reference Citation Analysis]
113 Nanashima A, Abo T, Nonaka T, Fukuoka H, Hidaka S, Takeshita H, Ichikawa T, Sawai T, Yasutake T, Nakao K. Prognosis of patients with hepatocellular carcinoma after hepatic resection: are elderly patients suitable for surgery? J Surg Oncol. 2011;104:284-291. [PMID: 21462192 DOI: 10.1002/jso.21932] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
114 Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, Ercolani G, Festi D, Pinna AD. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2012;256:706-712; discussion 712-713. [PMID: 23095613 DOI: 10.1097/sla.0b013e3182724ce8] [Cited by in Crossref: 96] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
115 Zuo SR, Zuo XC, He Y, Fang WJ, Wang CJ, Zou H, Chen P, Huang LF, Huang LH, Xiang H, Liu SK. Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. J Cancer 2018;9:321-30. [PMID: 29344279 DOI: 10.7150/jca.22218] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
116 Honmyo N, Kobayashi T, Kuroda S, Oshita A, Onoe T, Kohashi T, Fukuda S, Ohmori I, Abe T, Imaoka Y, Akita T, Tanaka J, Ohdan H. A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma. HPB 2021;23:134-43. [DOI: 10.1016/j.hpb.2020.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Chan SC, Fan ST, Chok KS, Cheung TT, Chan AC, Fung JY, Poon RT, Lo CM. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int. 2012;6:646-656. [PMID: 22016140 DOI: 10.1007/s12072-011-9318-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
118 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
119 Abrishami A, Nasseri-moghaddam S, Eghtesad B, Sherman M, Abrishami A. Surgical resection for hepatocellular carcinoma. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd006935] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
120 Yang P, Yuan W, He J, Wang J, Yu L, Jin X, Hu Y, Liao M, Chen Z, Zhang Y. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis. Hepatology Research 2009;39:1169-77. [DOI: 10.1111/j.1872-034x.2009.00563.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
121 Lee DH, Lee JM, Yi N, Lee K, Suh K, Lee J, Lee KB, Han JK. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma. Eur Radiol 2017;27:1713-21. [DOI: 10.1007/s00330-016-4499-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
122 Liu S, Li X, Li H, Guo L, Zhang B, Gong Z, Zhang J, Ye Q. Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection: Pringle Maneuver Affects HCC Recurrence. J Surg Oncol 2016;114:112-8. [DOI: 10.1002/jso.24271] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
123 Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, Ba-Ssalamah A. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology. 2013;269:777-786. [PMID: 23942606 DOI: 10.1148/radiol.13130210] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
124 Kim HS, Yi NJ, Kim JM, Joh JW, Lee KW, Suh KS. Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection. Ann Surg Treat Res 2021;101:85-92. [PMID: 34386457 DOI: 10.4174/astr.2021.101.2.85] [Reference Citation Analysis]
125 Shimoda M, Iwasaki Y, Kubota K. Harmonic curved shears system prevent of bile leakage after liver resection in a pig model. Int Surg 2014;99:632-9. [PMID: 25216434 DOI: 10.9738/INTSURG-D-13-00078.1] [Reference Citation Analysis]
126 Huang XQ, Zhang XF, Xia JH, Chao J, Pan QZ, Zhao JJ, Zhou ZQ, Chen CL, Tang Y, Weng DS, Zhang JH, Xia JC. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer. Chin J Cancer 2017;36:77. [PMID: 28950898 DOI: 10.1186/s40880-017-0240-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
127 Zhang HM, Jiang WT, Pan C, Deng YL, Zheng H, Shen ZY. Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation. Transplant Proc 2015;47:438-44. [PMID: 25769587 DOI: 10.1016/j.transproceed.2014.10.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
128 Chan ACY, Poon RTP, Ng KKC, Lo CM, Fan ST, Wong J. Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening. Annals of Surgery 2008;247:666-73. [DOI: 10.1097/sla.0b013e31816a747a] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 4.9] [Reference Citation Analysis]
129 Guo J, Yao F, Lou Y, Xu C, Xiao B, Zhou W, Chen J, Hu Y, Liu Z. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR. J Clin Gastroenterol 2007;41:783-8. [PMID: 17700428 DOI: 10.1097/01.mcg.0000247996.19710.f2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
130 Mason MC, Massarweh NN, Salami A, Sultenfuss MA, Anaya DA. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB (Oxford) 2015;17:1137-44. [PMID: 26374137 DOI: 10.1111/hpb.12487] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
131 Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer 2011;47:2299-305. [PMID: 21683576 DOI: 10.1016/j.ejca.2011.05.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
132 Luo J, Xu L, Li L, Zhang J, Zhang M, Xu M. Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma. J Gastrointest Oncol 2021;12:2377-87. [PMID: 34790399 DOI: 10.21037/jgo-21-491] [Reference Citation Analysis]
133 Choi SB, Kim HJ, Song TJ, Ahn HS, Choi SY. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 2014;21:639-47. [DOI: 10.1002/jhbp.124] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
134 Peng W, Zhang XY, Li C, Wen TF, Yan LN, Yang JY. Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma. Medicine (Baltimore). 2019;98:e15458. [PMID: 31045820 DOI: 10.1097/md.0000000000015458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
135 Trotta Mde R, Cajaiba DM, Parra OM, Dagli ML, Hernandez-Blazquez FJ. Parenteral solution of nutritional hepatotrophic factors improves regeneration in thioacetamide-induced cirrhotic livers after partial hepatectomy. Toxicol Pathol 2014;42:414-21. [PMID: 23615430 DOI: 10.1177/0192623313486316] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
136 Tang TC, Man S, Lee CR, Xu P, Kerbel RS. Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma. Neoplasia 2010;12:264-74. [PMID: 20234820 DOI: 10.1593/neo.91872] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
137 Luo C, Pu J, Liu F, Long X, Wang C, Wei H, Tang Q. MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis. Clin Res Hepatol Gastroenterol 2019;43:715-21. [PMID: 30962170 DOI: 10.1016/j.clinre.2019.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Eur J Surg Oncol. 2012;38:683-691. [PMID: 22621971 DOI: 10.1016/j.ejso.2012.04.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
139 Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005;237:520-528. [PMID: 16192317 DOI: 10.1148/radiol.2372041183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
140 Puneet P, Perera MTPR, Mirza DF. Current opinion on the role of resection and liver transplantation for hepatocellular cancer. Indian J Gastroenterol 2012;31:89-99. [DOI: 10.1007/s12664-012-0200-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
141 Harada K, Nagayama M, Ohashi Y, Chiba A, Numasawa K, Meguro M, Kimura Y, Yamaguchi H, Kobayashi M, Miyanishi K, Kato J, Mizuguchi T. Scoring criteria for determining the safety of liver resection for malignant liver tumors. World J Meta-Anal 2019; 7(5): 234-248 [DOI: 10.13105/wjma.v7.i5.234] [Reference Citation Analysis]
142 Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One. 2013;8:e57882. [PMID: 23483935 DOI: 10.1371/journal.pone.0057882] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
143 Liu AM, Yao TJ, Wang W, Wong KF, Lee NP, Fan ST, Poon RT, Gao C, Luk JM. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012;2:e000825. [PMID: 22403344 DOI: 10.1136/bmjopen-2012-000825] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 15.8] [Reference Citation Analysis]
144 Nanashima A, Tobinaga S, Masuda J, Miyaaki H, Taura N, Takeshita H, Hidaka S, Sawai T, Nakao K, Nagayasu T. Selecting treatment for hepatocellular carcinoma based on the results of hepatic resection and local ablation therapy. J Surg Oncol 2010;101:481-5. [PMID: 20191611 DOI: 10.1002/jso.21523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
145 Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg 2010; 2(4): 137-142 [PMID: 21160862 DOI: 10.4240/wjgs.v2.i4.137] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
146 He S, Zhang DC, Wei C. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis. Clin Res Hepatol Gastroenterol. 2015;39:426-434. [PMID: 25746139 DOI: 10.1016/j.clinre.2015.01.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
147 Huang Z, Huang J, Zhou T, Cao H, Tan B. Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis. PLoS One 2018;13:e0190512. [PMID: 29324802 DOI: 10.1371/journal.pone.0190512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
148 Huang X, Lai Y, Yao N, Cui Y, Yu X, Cai Z, Tang Y, Huang Y, Zeng J. High expression of microRNA-1266 in hepatocellular carcinoma is associated with poor prognosis of patients and biological cell growth. Oncol Lett 2021;21:347. [PMID: 33747204 DOI: 10.3892/ol.2021.12608] [Reference Citation Analysis]
149 Zhang H, Yuan SX, Dai SY, Zhang JM, Huang X, Lu CD, Lu JH, Wu FQ, Lau WY, Wu MC, Yang T, Shen F. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion. World J Surg 2014;38:947-57. [PMID: 24258262 DOI: 10.1007/s00268-013-2365-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
150 Li J, Zhu YH, Huang P, Zhang B, Sun J, Guan XY. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma. Diagn Pathol 2015;10:136. [PMID: 26249031 DOI: 10.1186/s13000-015-0374-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
151 Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, Zhao G. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Sci Rep 2015;5:8087. [PMID: 25627001 DOI: 10.1038/srep08087] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 10.3] [Reference Citation Analysis]
152 Chang WT, Liu W, Chiu YH, Chen BH, Chuang SC, Chen YC, Hsu YT, Lu MJ, Chiou SJ, Chou CK, Chiu CC. A 4-Phenoxyphenol Derivative Exerts Inhibitory Effects on Human Hepatocellular Carcinoma Cells through Regulating Autophagy and Apoptosis Accompanied by Downregulating α-Tubulin Expression. Molecules 2017;22:E854. [PMID: 28531143 DOI: 10.3390/molecules22050854] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
153 Liang BY, Gu J, Xiong M, Zhang EL, Zhang ZY, Chen XP, Huang ZY. Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy. Sci Rep 2021;11:16343. [PMID: 34381132 DOI: 10.1038/s41598-021-95835-5] [Reference Citation Analysis]